Au nom du Comité scientifique de Targeting Mitochondria 2012, nous sommes honorés d’accueillir des intervenants de haut niveau qualité pour la troisième édition du congrès international Targeting Mitochondria 2012, qui se tiendra à Berlin, les 8 et 9 Novembre 2012.
Parmi les Conférenciers de l’édition 2012:
Douglas Wallace, Center for Mitochondrial and Epigenomics Medicine, Philadelphia, USA
General Introduction of Targeting Mitochondria 2012: Mitochondria: Huge Steps to New Medicine
Thomas Becker, Institute for Biochemistry and Molecular Biology, Freiburg, Germany
Importing Mitochondrial Proteins: Lessons & Perspectives to Target Mitochondria
Richard Hartley, University of Glasgow, Glasgow, United Kingdom
Targeting Mitochondria by « Magic Molecules »: Strategic Role of Chemistry
The MitoB Advantages: a Probe for Assessing Oxidative Stress
Mary Herbert, Institute for Ageing and Health, Newcastle, UK
Mitochondria Gene Replacement & Engineering Mitochondria: New Options and Perspectives for Prevention of Mitochondrial Diseases
Rejko Krüger, University of Tuebingen, Tuebingen, Germany
Targeting Mitochondrial Dynamics as Therapeutic Approach: New Perspectives for Neurodegeneration in Parkinson’s disease
Afshan Malik, King’s College London, Diabetes research Group, School of Medicine, London, United Kingdom
Mitochondrial DNA Content and Metabolic/hyperglycaemic Memory: is there a Connection?
Paulo Oliveira, University of Coimbra, Coimbra, Portugal
Mitochondria as a Perfect Drug Target in Health and Disease
Brendan Payne, Institute of Genetic Medicine, Newcastle University, Newcastle, UK
Mitochondrial Aging is Accelerated by Anti-Retroviral Therapy through the Clonal Expansion of mtDNA Mutations
Alessandro Prigione, Max-Planck Institue for Molecular Genetics, Berlin, Germany
Stem Cells, Regenerative Medicine & Mitochondria: Subtle Regulation & Perspectives
iPS Cells (induced Pluripotent Stem Cells) and Mitochondrial Rejuvenation: Fact or Fiction?
Michael Teitell, David Geffen School of Medicine at UCLA, Los Angeles, USA
Correcting Human Mitochondrial Mutations with Targeted RNA Import: Recent Advances and Perspectives for Mitochondria Medicine
Yuma Yamada, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan
Mitochondrial Delivery of Nucleic Acids by DF-MITO-Porter toward Mitochondrial Gene Therapy
Antonio Zorzano, Institute for Research in Biomedicine, Barcelona, Spain
Diabetes and Mitochondria Alteration: Mitofusin 2 as a Potential Target for the Treatment of Diabetes Type 2